Showing 661 - 680 results of 1,055 for search '"allergy"', query time: 0.05s Refine Results
  1. 661

    A Pharmacological and Toxicological Profile of Silver as an Antimicrobial Agent in Medical Devices by Alan B. G. Lansdown

    Published 2010-01-01
    “…Minimum blood silver levels consistent with early signs of argyria or argyrosis are not known. Silver allergy does occur but the extent of the problem is not known. …”
    Get full text
    Article
  2. 662

    Dr Punctal Polyp, First Case Presentation by Nazia Qidwai

    Published 2024-06-01
    “…There was no systemic history of any allergy or use of any anti-allergic drugs. An excisional biopsy of these lesions was done and sent for histopathology. …”
    Get full text
    Article
  3. 663

    Recent Advances of Processing and Detection Techniques on Crustacean Allergens: A Review by Xin Qu, Zekun Ma, Xuli Wu, Liangtao Lv

    Published 2025-01-01
    “…This review provides updates and new findings on crustacean allergens, which helps better understand crustacean allergy and provide novel strategies for its prevention and management.…”
    Get full text
    Article
  4. 664
  5. 665

    Listeria monocytogenes Meningoencephalitis and Cerebral Abscess in a Heart Transplant Recipient by Paul C. Adjei

    Published 2020-01-01
    “…However, he reported amoxicillin allergy. Desensitization to ampicillin failed because ampicillin was too unstable per the allergist. …”
    Get full text
    Article
  6. 666
  7. 667

    Role of Zinc Signaling in the Regulation of Mast Cell-, Basophil-, and T Cell-Mediated Allergic Responses by Keigo Nishida, Ryota Uchida

    Published 2018-01-01
    “…We also describe zinc signaling dysregulation as a leading health problem in inflammatory disease and allergy.…”
    Get full text
    Article
  8. 668

    Allergen Induced Increase in Nonallergic Airway Responsiveness: A Citation Classic Revisited by Donald W Cockcroft

    Published 2000-01-01
    “…BACKGROUND:The present paper revisits the 1977 paper by DW Cockcroft, RE Ruffin, the late J Dolovich and FE Hargreave entitled "Allergen-induced increase in nonallergic bronchial reactivity" (Clin Allergy 1977;7:503-13) that became a citation classic. …”
    Get full text
    Article
  9. 669

    Abdominal attack in a patient with hereditary angioedema due to C1 inhibitor deficiency complicated by a perforated peptic ulcer by Piotr Obtulowicz, Marcin Stobiecki, Wojciech Dyga, Tadeusz Popiela, Krystyna Obtulowicz

    Published 2024-02-01
    “…A few hours later abdominal symptoms recurred and erythema appeared, thus the allergy to antispasmodic drug taken by the patient was suspected. …”
    Get full text
    Article
  10. 670

    Study of some parameters of humoral immunity in asthmatic elderly patients by Marisela Pérez Pacareu, Alina González Paredes, Rafael Zamora Puerta, Dayamí García Torres

    Published 2008-12-01
    “…All of them were received in Cienfuegos Allergy External Consultation, during one year and quantities of immunoglobulin G, A and M were measured. …”
    Get full text
    Article
  11. 671

    Functional Properties and Molecular Architecture of Leukotriene A4 Hydrolase, a Pivotal Catalyst of Chemotactic Leukotriene Formation by Jesper Z. Haeggström, Pär Nordlund, Marjolein M.G.M. Thunnissen

    Published 2002-01-01
    “…The leukotrienes are a family of lipid mediators involved in inflammation and allergy. Leukotriene B4 is a classical chemoattractant, which triggers adherence and aggregation of leukocytes to the endothelium at only nM concentrations. …”
    Get full text
    Article
  12. 672
  13. 673
  14. 674
  15. 675
  16. 676

    Experiences of Oral Corticosteroid Use and Adverse Effects: A National Cross-Sectional Survey of People with Asthma by Jones AW, McDonald VM, McLoughlin RF, Vella TM, Flynn AW, Blakey JD, Wolfenden L, Hew M, Upham JW, Thomas D, Bardin P, Holland AE

    Published 2025-01-01
    “…Arwel W Jones,1 Vanessa M McDonald,2– 5 Rebecca F McLoughlin,2– 4 Teresa M Vella,6 Anthony W Flynn,7 John D Blakey,8,9 Luke Wolfenden,10,11 Mark Hew,12 John W Upham,13,14 Dennis Thomas,2,4 Philip Bardin,15 Anne E Holland1,2,16 1Respiratory Research@Alfred, Monash University, Melbourne, VIC, Australia; 2Centre of Excellence in Treatable Traits, University of Newcastle, Newcastle, NSW, Australia; 3School of Nursing and Midwifery, University of Newcastle, Newcastle, NSW, Australia; 4Hunter Medical Research Institute Asthma and Breathing Program, Newcastle, NSW, Australia; 5Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; 6Brand and Engagement, Asthma Australia, Brisbane, QLD, Australia; 7Research, Information and Evaluation, Asthma Australia, Melbourne, VIC, Australia; 8Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia; 9Medical School, Curtin University, Perth, WA, Australia; 10Hunter New England Population Health, Wallsend, NSW, Australia; 11School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; 12Allergy, Asthma & Clinical Immunology, Alfred Health, Melbourne, VIC, Australia; 13Frazer Institute, University of Queensland, Brisbane, QLD, Australia; 14Department of Respiratory Medicine, Princess Alexandra Hospital, Brisbane, QLD, Australia; 15Monash Lung Sleep Allergy & Immunology, Monash University and Medical Centre, Clayton, VIC, Australia; 16Physiotherapy Department, Alfred Health, Melbourne, VIC, AustraliaCorrespondence: Arwel W Jones, Respiratory Research@Alfred, School of Translational Medicine, Monash University, Alfred Centre, Melbourne, VIC, 3004, Australia, Email arwel.jones@monash.eduPurpose: Oral corticosteroids (OCS) are an effective treatment for severe uncontrolled asthma or asthma exacerbations, but frequent bursts or long-term use carry serious and sometimes irreversible adverse effects, or complications such as adrenal insufficiency upon discontinuation. …”
    Get full text
    Article
  17. 677

    Chronic Rhinosinusitis with Nasal Polyps and Biologics: A Call for Better Data Standardisation and Presentation in Clinical Studies by Kariyawasam HH, Langan D, Rimmer J

    Published 2025-01-01
    “…Harsha Hemantha Kariyawasam,1,2 Dean Langan,3 Joanne Rimmer4– 6 1Specialist Allergy and Clinical Immunology, Royal National ENT Hospital, London, UK; 2Rhinology Section, Royal National ENT Hospital, London, UK; 3Great Ormond Street Institute of Child Health, UCL, London, UK; 4Department of Otolaryngology Head & Neck Surgery, Monash Health, Melbourne, Australia; 5Department of Surgery, Monash University, Melbourne, Australia; 6Department of Otolaryngology Head & Neck Surgery, St Vincent’s Hospital, Melbourne, AustraliaCorrespondence: Harsha Hemantha Kariyawasam, Specialist Allergy and Clinical Immunology, Rhinology Section, Royal National ENT Hospital London and UCLH NHS Foundation Trust, 47-49 huntley Street, London, WC1E 6DG, UK, Email harsha.kariyawasam@nhs.netAbstract: Chronic rhinosinusitis with nasal polyps (CRSwNP) is often severe, debilitating and difficult to treat. …”
    Get full text
    Article
  18. 678

    The immune landscape and viral shedding of Omicron SARS-CoV-2 variants implicate immune escape by Weilong Zhang, Xiaoyan Gai, Zhonghui Duan, Changjian Yan, Chunyuan Huang, Chaoling Wu, Siping Zheng, Zixiang Lin, Qingtao Zhou, Lili Dai, Ping Yang, Fang Bao, Hongmei Jing, Chao Cai, Yingmin Ma, Yongchang Sun

    Published 2025-01-01
    “…However, there was no statistically significant correlation between viral shedding duration and immune-related indicators, such as WBC, Hb, PLT, Neu, Lym, CRP, allergy, fever, and vaccination status (p > 0.05). …”
    Get full text
    Article
  19. 679

    Prevalence of Myocardial Infarction With Obstructive and Non-Obstructive Coronary Arteries in a Middle-Aged Population With Chronic Airflow Limitation: A Cross-Sectional Study by Sundh J, Ekström M, Blomberg A, Lindberg E, Malinovschi A, Olin AC, Sköld CM, Torén K, Wollmer P, Östgren CJ, Jernberg T

    Published 2025-02-01
    “…Josefin Sundh,1 Magnus Ekström,2 Anders Blomberg,3 Eva Lindberg,4 Andrei Malinovschi,5 Anna-Carin Olin,6 C Magnus Sköld,7,8 Kjell Torén,6 Per Wollmer,6 Carl Johan Östgren,9,10 Tomas Jernberg11,12 1Department of Respiratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; 2Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Respiratory Medicine, Allergology and Palliative Medicine, Lund, Sweden; 3Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; 4Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden; 5Department of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden; 6Occupational and Environmental Medicine, School of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 7Respiratory Medicine Unit, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; 8Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden; 9Department of Translational Medicine, Lund University, Malmö, Sweden; 10Centre of Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden; 11Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; 12Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, SwedenCorrespondence: Josefin Sundh, Department of Respiratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, 701 82, Sweden, Tel +46702349517, Email josefin.sundh@regionorebrolan.se; josefin.sundh@oru.sePurpose: Myocardial infarctions (MIs) can occur in underlying obstructive coronary artery disease (MI-CAD) or in non-obstructive coronary arteries (MINOCA). …”
    Get full text
    Article
  20. 680